S Squared Technology LLC Buys Shares of 2,055,271 DocGo Inc. $DCGO

S Squared Technology LLC acquired a new position in shares of DocGo Inc. (NASDAQ:DCGOFree Report) in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 2,055,271 shares of the company’s stock, valued at approximately $1,060,725. S Squared Technology LLC owned about 2.08% of DocGo as of its most recent SEC filing.

A number of other large investors have also recently bought and sold shares of the business. Renaissance Technologies LLC boosted its holdings in DocGo by 167.1% in the 1st quarter. Renaissance Technologies LLC now owns 1,510,361 shares of the company’s stock worth $950,000 after buying an additional 944,826 shares during the period. BNP Paribas Financial Markets lifted its position in DocGo by 411.3% in the third quarter. BNP Paribas Financial Markets now owns 81,482 shares of the company’s stock worth $111,000 after buying an additional 65,545 shares during the last quarter. Squarepoint Ops LLC raised its stake in DocGo by 246.3% in the fourth quarter. Squarepoint Ops LLC now owns 94,511 shares of the company’s stock worth $83,000 after buying an additional 67,216 shares in the last quarter. Strs Ohio acquired a new stake in shares of DocGo in the first quarter worth $76,000. Finally, Jain Global LLC purchased a new position in DocGo in the 4th quarter valued at $70,000. 56.44% of the stock is currently owned by institutional investors and hedge funds.

DocGo Stock Down 4.0%

Shares of NASDAQ:DCGO traded down $0.02 during midday trading on Friday, reaching $0.40. The company’s stock had a trading volume of 334,154 shares, compared to its average volume of 910,084. The firm has a market capitalization of $39.40 million, a PE ratio of -0.20 and a beta of 0.99. The stock has a fifty day moving average of $0.57 and a 200 day moving average of $0.62. DocGo Inc. has a twelve month low of $0.35 and a twelve month high of $1.65.

DocGo (NASDAQ:DCGOGet Free Report) last issued its earnings results on Monday, August 17th. The company reported ($0.16) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.10) by ($0.06). DocGo had a negative net margin of 65.29% and a negative return on equity of 40.42%. The company had revenue of $73.42 million during the quarter, compared to analyst estimates of $75.35 million. Sell-side analysts anticipate that DocGo Inc. will post -0.22 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several analysts have recently weighed in on the stock. Needham & Company LLC reaffirmed a “buy” rating and issued a $3.00 target price on shares of DocGo in a report on Tuesday, August 18th. Wall Street Zen raised DocGo from a “sell” rating to a “hold” rating in a report on Saturday, May 16th. Cantor Fitzgerald reissued an “overweight” rating on shares of DocGo in a report on Monday, May 11th. Canaccord Genuity Group reissued a “hold” rating and issued a $1.00 target price on shares of DocGo in a research report on Tuesday, August 18th. Finally, Weiss Ratings restated a “sell (e+)” rating on shares of DocGo in a report on Thursday, June 18th. Three investment analysts have rated the stock with a Buy rating, two have given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, DocGo has a consensus rating of “Hold” and a consensus price target of $2.38.

Read Our Latest Research Report on DCGO

About DocGo

(Free Report)

DocGo, Inc is a U.S.-based integrated healthcare company that delivers on-demand and mobile healthcare services. The company’s business model centers on deploying customized medical clinics paired with a digital care platform to bring primary and acute care directly to patients. Through a combination of telemedicine and over-the-road medical units, DocGo addresses routine medical exams, chronic disease management, occupational health screenings, specialist consultations and urgent care interventions.

In addition to its mobile clinic fleet, DocGo’s digital platform offers 24/7 virtual care, facilitating remote consultations via video, phone or secure messaging.

See Also

Institutional Ownership by Quarter for DocGo (NASDAQ:DCGO)

Receive News & Ratings for DocGo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocGo and related companies with MarketBeat.com's FREE daily email newsletter.